Modelling ALS Requires ‘Aged’ Stem Cells
News Jul 20, 2016
Cedars-Sinai scientists are seeking to build an improved stem-cell model of amyotrophic lateral sclerosis (ALS) to accelerate progress toward a cure for the devastating neurological disorder. Their findings demonstrate that current models can be enhanced by the aging of motor neurons to show how ALS damages cells later in life.
ALS, also known as Lou Gehrig’s disease, affects more than 12,000 people in the U.S., according to the National Institutes of Health. It typically strikes between the ages of 40 and 70, according to the ALS Association. There are no effective treatments, and most patients suffer paralysis and die within five years of diagnosis.
To understand ALS, researchers at the Cedars-Sinai Board of Governors Regenerative Medicine Institute are creating induced pluripotent stem cells (iPSCs) derived from patients’ skin cells. By altering several genes in patients’ cells, the investigators can return these cells to their embryonic, or stem-cell, state. These specially engineered stem cells reproduce indefinitely in laboratory dishes, where their abnormalities and processes can be examined in detail. In the case of ALS, these cells are used to grow spinal motor neurons and study them.
A multi-center team led by Clive Svendsen, PhD, and Ritchie Ho, PhD, has found that iPSC versions of spinal motor neurons typically used to model ALS resemble immature or fetal neurons more than mature adult neurons in adults affected by the disease. In a detailed analysis of large sets of genes, the investigators also showed how ALS may impact neurons as they mature and exacerbate age-related changes.
Taken together, the findings suggest that investigators need to devise ways to alter iPSC versions of spinal motor neurons to more closely resemble older versions found in adult ALS patients, the scientists said. “Using motor neurons to model neurological disease may require their aging in a dish,” said Ho, the first author of an article on the study, published online July 18 in the journal Nature Neuroscience.
To help researchers tackle the task of aging the stem cells, the group identified a series of genetic markers to assess cell maturity and age.
“By knowing the gene expression patterns that define adult motor neurons in the spinal cord, we can push the iPSC-derived motor neurons in the right direction in the petri dish,” said Svendsen, director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences.
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
Researchers are One Step Closer to Developing Eye Drops to Treat Age-Related Macular DegenerationNews
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).READ MORE